Also trades as: KYNB (NASDAQ) · $vol 0M
0IL8.L LSE
Kyntra Bio, Inc.
1W: -6.9%
1M: -24.0%
3M: -17.1%
YTD: -20.6%
1Y: -32.4%
3Y: -89.7%
$6.36
-0.51 (-7.42%)
Weekly Expected Move ±5.9%
$6
$6
$6
$7
$7
Overview
News
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$120M
-44.3% ▼
5Y CAGR: -32.1%
Total Liabilities
$115M
-71.1% ▼
5Y CAGR: -21.5%
Shareholders Equity
$4M
+102.0% ▲
5Y CAGR: -59.7%
Cash & Investments
$89M
+76.3% ▲
5Y CAGR: -33.5%
Total Debt
$0
-100.0% ▼
Net Debt
-$48M
-220.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $171M | $156M | $114M | $50M | $48M |
| Short-Term Investments | $234M | $266M | $122M | $0 | $41M |
| Cash & ST Investments | $405M | $422M | $236M | $50M | $89M |
| Net Receivables | $25M | $16M | $41M | $481K | $216K |
| Inventory | $31M | $40M | $42M | $3M | $4M |
| Other Current Assets | $5M | $4M | $7M | $140M | $6M |
| Total Current Assets | $474M | $493M | $332M | $197M | $99M |
| Property, Plant & Equip. | $119M | $100M | $81M | $97K | $0 |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $172M | $9M | $5M | $0 | $20M |
| Other Non-Current Assets | $9M | $7M | $5M | $18M | $361K |
| Total Non-Current Assets | $300M | $117M | $92M | $18M | $21M |
| Total Assets | $774M | $610M | $424M | $215M | $120M |
| — Liabilities — | |||||
| Accounts Payable | $26M | $31M | $18M | $5M | $4M |
| Short-Term Debt | $0 | $0 | $40K | $0 | $0 |
| Deferred Revenue | $19M | $13M | $13M | $0 | $5M |
| Other Current Liabilities | $5M | $7M | $153M | $115M | $20M |
| Total Current Liabilities | $225M | $274M | $218M | $133M | $29M |
| Long-Term Debt | $0 | $0 | $90M | $90M | $0 |
| Other Non-Current Liab. | $44M | $73M | $54M | $175M | $86M |
| Total Non-Current Liabilities | $319M | $338M | $368M | $265M | $86M |
| Total Liabilities | $545M | $612M | $586M | $398M | $115M |
| — Equity — | |||||
| Common Stock | $929K | $942K | $988K | $1M | $1M |
| Retained Earnings | -$1.3B | -$1.6B | -$1.8B | -$1.9B | -$1.7B |
| Accumulated OCI | -$4M | -$6M | -$7M | -$6M | -$2M |
| Total Stockholders Equity | $209M | -$21M | -$204M | -$226M | $4M |
| Total Liabilities & Equity | $774M | $610M | $424M | $215M | $120M |
| — Key Metrics — | |||||
| Total Debt | $100M | $90M | $170M | $90M | $0 |
| Net Debt | -$72M | -$66M | $57M | $40M | -$48M |
| Total Investments | $406M | $276M | $127M | $0 | $61M |